Home » Topics » BioWorld

BioWorld
RSS

COLLAGEN CUTS COSTS 11 PERCENT

June 23, 1992

AMYLIN FILES IND FOR INSULIN SHOCK DRUG

June 23, 1992

ROCHE SHIPS COMBINATION AIDS TREATMENT

June 23, 1992

ENZON SCA PROTEINS EDGE MABS IN TEST

June 22, 1992

SYSTEMIX TO COLLABORATE WITH SANDOZ

June 22, 1992

TSI TIGHTENS ITS FOCUS, SEES PROFIT IN '93

June 22, 1992

SCICLONE FORMS JAPANESE SUBSIDIARY

June 22, 1992

APPOINTMENTS AND ADVANCEMENTS

June 22, 1992

SEC APPROVES BIO-IMAGING OFFERING

June 22, 1992

CO-DEVELOPMENT PACT FOR INHALER DEVICE

June 22, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....